About
MIM Fertility is a medical AI company delivering a holistic suite of AI/ML-powered products designed to elevate the quality and efficiency of in vitro fertilization (IVF) care. Its three core products serve distinct stages of the fertility treatment workflow. FOLLISCAN is a CE-marked, FDA 510(k)-cleared ovarian follicular monitoring tool that works with both 2D and 3D ultrasounds, integrates with ultrasound machines and EMR systems, and achieves 97% measurement accuracy. It significantly reduces per-patient scan time, allowing clinics to see more patients without sacrificing care quality. EMBRYOAID is a CE-marked embryo assessment tool that works with both static images and time-lapse video from microscopes and incubators. It achieves an 86.4% match rate with expert embryologist committee decisions, providing a validated second opinion for embryo selection and improving implantation success rates. ENDOSCAN measures endometrial thickness and volume in seconds, generates ready-to-share AI reports, and supports optimal embryo transfer timing decisions. Across all products, MIM Fertility emphasizes standardization across clinics, data-backed precision to support expert judgment, and operational efficiency to reduce clinician mental burden. The platform is backed by peer-reviewed medical and AI publications and is trusted by leading fertility centers worldwide. It is best suited for IVF clinics, fertility specialists, embryologists, and reproductive medicine labs seeking to integrate AI into daily clinical workflows.
Key Features
- FOLLISCAN – AI Ovarian Monitoring: CE-marked and FDA 510(k)-cleared tool that analyzes 2D and 3D ultrasounds with 97% measurement accuracy, integrating directly with ultrasound machines and EMR systems.
- EMBRYOAID – AI Embryo Assessment: Evaluates embryos from images and time-lapse video, matching expert embryologist committee decisions at 86.4% accuracy to support optimal embryo selection.
- ENDOSCAN – Endometrial Receptivity Measurement: Measures uterine lining thickness and volume in seconds and generates ready-to-share AI reports to guide embryo transfer timing.
- EMR & Device Integration: Connects with existing ultrasound machines, microscopes, incubators, and electronic medical record systems for seamless workflow adoption.
- Standardization Across Clinics: Ensures consistent, high-quality assessments across all clinic locations and lab teams using AI-driven copilots and validated algorithms.
Use Cases
- Fertility clinics using AI to standardize and speed up ovarian follicle measurement during IVF monitoring cycles.
- Embryologists leveraging EMBRYOAID as a second-opinion AI tool to improve embryo selection accuracy and implantation success rates.
- Reproductive endocrinologists using ENDOSCAN to quickly assess endometrial thickness and volume for optimal embryo transfer timing.
- IVF lab directors integrating MIM Fertility's suite into their EMR and device ecosystem to reduce staff workload and mental burden.
- Multi-site fertility networks deploying MIM Fertility tools to ensure consistent, standardized assessment quality across all clinic locations.
Pros
- Clinically Validated Accuracy: Products are backed by peer-reviewed publications, CE marking, and FDA 510(k) clearance, giving clinicians confidence in AI-assisted decisions.
- Deep Workflow Integration: Integrates with ultrasound machines, incubators, microscopes, and EMR systems, minimizing disruption to existing clinical workflows.
- Time & Efficiency Gains: Reduces per-patient assessment time, enabling clinics to handle higher patient volumes without compromising quality of care.
- Holistic IVF Coverage: Covers all three critical IVF decision points — follicle monitoring, embryo selection, and endometrial receptivity — in a single platform.
Cons
- Enterprise-Only Pricing: No self-serve pricing is publicly available; access requires requesting a demo, making it inaccessible to smaller or independent practices without a sales process.
- Specialized Use Case: Purpose-built exclusively for fertility and IVF clinics, limiting applicability to other medical or diagnostic specialties.
- Regulatory Dependency by Region: CE and FDA clearances are the primary regulatory badges; availability in regions with different regulatory frameworks may vary.
Frequently Asked Questions
What products does MIM Fertility offer?
MIM Fertility offers three AI/ML-powered tools: FOLLISCAN for ovarian follicular monitoring, EMBRYOAID for 5-day embryo assessment, and ENDOSCAN for endometrial receptivity measurement.
Is FOLLISCAN FDA-approved?
Yes. FOLLISCAN has received FDA 510(k) clearance, placing MIM Fertility among an elite group of global medical AI innovators meeting the world's most rigorous safety standards. It is also CE-marked.
How accurate is EMBRYOAID compared to human embryologists?
EMBRYOAID achieves an 86.4% match rate with expert embryologist committee decisions, and a multicentre IVF study published in RBMO found AI embryo selection achieved 70.1% accuracy, outperforming most individual embryologists.
Does MIM Fertility integrate with existing clinic systems?
Yes. All products are designed to integrate with existing ultrasound machines, microscopes, incubators, and electronic medical record (EMR) systems to fit naturally into established clinical workflows.
How can I get access to MIM Fertility's tools?
Access is available by requesting a demo through the MIM Fertility website. The platform is designed for fertility clinics and reproductive medicine labs rather than individual consumers.
